Conexeu Sciences Inc (CNXU)

$10.34 +0.14 (1.37%)
Market Cap 272.93M
Revenue (ttm) 0.00
Net Income (ttm) -3.92M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 273,200
Avg Vol N/A
Day's Range N/A - N/A
Shares Out 26.76M
Stochastic %K 64%
Beta N/A
Analysts Sell
Price Target $20.00

Company Profile

Conexeu Sciences Inc. develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics and tissue repair. The company provides patented collagen-based scaffold products, including a collagen extracellular matrix (ECM) scaffold platform for use in medical aesthetics, wound care, tissue repair, facial rejuvenation, and large-volume body contouring such as face, breast, and butt volume restoration. Its CXU collagen gel is an investigational product targeting ther...

Industry: Biotechnology
Sector: Healthcare
Phone: (604) 315-4722
Address:
50 West Liberty Street, Suite 880, Reno, United States
AnUnwiseInvestor
AnUnwiseInvestor Jul. 13 at 11:24 PM
$CNXU I got a letter in the mail from Robert Kiyosaki saying I should buy this.
0 · Reply
twitsblast
twitsblast Jul. 7 at 3:32 PM
$CNXU 🚨 $CHAI names new CFO, formerly with $RGNT, $GLMD, and $PLRZ. 💥
0 · Reply
stocks_2watch
stocks_2watch Jul. 7 at 1:46 PM
Look…the preclinical data on their Ten-Minute Tissue injectable looks promising for wound care but $CNXU is still pre-revenue with a fast burn rate. The latest 10Q showed a $2.3M net loss for the quarter and zero revenue. expanding their footprint at the new Vancouver adMare M4 hub is a great long-term move to scale the CXU platform, preclinical biotech burns cash fast. Still have trust but being carefull
0 · Reply
Mikiminingmouse
Mikiminingmouse Jul. 3 at 3:21 PM
$CNXU Big step forward them, with opening of their new Vancouver R&D lab at the adMare hub. great to see them hit these operational milestones as they steadily build momentum toward their 2027 FDA 510(k) submission
0 · Reply
topstockalerts
topstockalerts Jul. 2 at 12:35 PM
Pre Market Top Gainers PT2 $SURG $SDEV $TENX $UPXI $CNXU
0 · Reply
stocks_2watch
stocks_2watch Jun. 26 at 12:15 PM
$CNXU is scaling up the formulation tech with their CDMO for the 2027 510k submission, smooth transition from research to manufacturing so if they hits timelines this bio-tissue play is going to be massive
0 · Reply
mrrobot1337
mrrobot1337 Jun. 26 at 10:40 AM
Fresh Nasdaq debut with $CNXU and they already rang the bell this month. No royalty or licensing baggage on their IP. Highly scalable ECM platform targeting huge markets like wound care, one of those?
0 · Reply
kate8delgado8
kate8delgado8 Jun. 24 at 11:01 AM
$CNXU
0 · Reply
harrijakey
harrijakey Jun. 24 at 10:57 AM
$CNXU
0 · Reply
masonRhiiine
masonRhiiine Jun. 24 at 10:56 AM
$CNXU
0 · Reply
Latest News on CNXU
The GLP-1s Are Creating Another Boom, a New $2 Billion Opportunity Exists in Aesthetics. Conexeu Is Building for It

Jul 14, 2026, 8:30 AM EDT - 4 hours ago

The GLP-1s Are Creating Another Boom, a New $2 Billion Opportunity Exists in Aesthetics. Conexeu Is Building for It

A $190 Billion Weight-Loss Boom Has Exposed a Tissue-Restoration Gap Today's Injectables Were Not Built to Fill

Jul 7, 2026, 9:00 AM EDT - 7 days ago

A $190 Billion Weight-Loss Boom Has Exposed a Tissue-Restoration Gap Today's Injectables Were Not Built to Fill

Conexeu Sciences Opens Vancouver R&D Facility to Advance Regenerative Tissue Platform

Jun 25, 2026, 8:30 AM EDT - 19 days ago

Conexeu Sciences Opens Vancouver R&D Facility to Advance Regenerative Tissue Platform

Conexeu Sciences initiated with a Buy at H.C. Wainwright

2026-06-22T10:05:06.000Z - 22 days ago

Conexeu Sciences initiated with a Buy at H.C. Wainwright

Conexeu Sciences appoints David Bogart as chief commercial officer

2026-06-15T13:11:02.000Z - 4 weeks ago

Conexeu Sciences appoints David Bogart as chief commercial officer

Conexeu Expands Board, Executive, and Advisory Leadership With Five Appointments Post Nasdaq Listing

Jun 15, 2026, 8:30 AM EDT - 4 weeks ago

Conexeu Expands Board, Executive, and Advisory Leadership With Five Appointments Post Nasdaq Listing

Conexeu Sciences Quarterly report: Q2 2026

Jun 15, 2026, 8:00 AM EDT - 4 weeks ago

Conexeu Sciences Quarterly report: Q2 2026

Conexeu Sciences provides update on manufacturing scale up for wound care device

2026-06-08T13:01:13.000Z - 5 weeks ago

Conexeu Sciences provides update on manufacturing scale up for wound care device

Conexeu Sciences Reports Manufacturing Scale Up and Regulatory Progress for Lead CXU™ Wound Care Program

Jun 8, 2026, 8:30 AM EDT - 5 weeks ago

Conexeu Sciences Reports Manufacturing Scale Up and Regulatory Progress for Lead CXU™ Wound Care Program

Conexeu Sciences to Ring Nasdaq Bell on June 10, 2026

Jun 3, 2026, 8:30 AM EDT - 5 weeks ago

Conexeu Sciences to Ring Nasdaq Bell on June 10, 2026

UPDATE - Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine

May 27, 2026, 10:36 AM EDT - 6 weeks ago

UPDATE - Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine

Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine

May 27, 2026, 8:30 AM EDT - 6 weeks ago

Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine

Conexeu Sciences Commences Trading on Nasdaq Under Ticker Symbol "CNXU"

May 21, 2026, 12:02 PM EDT - 7 weeks ago

Conexeu Sciences Commences Trading on Nasdaq Under Ticker Symbol "CNXU"

Conexeu Sciences opens at $13.50 after Nasdaq direct listing

2026-05-21T15:45:30.000Z - 7 weeks ago

Conexeu Sciences opens at $13.50 after Nasdaq direct listing

AnUnwiseInvestor
AnUnwiseInvestor Jul. 13 at 11:24 PM
$CNXU I got a letter in the mail from Robert Kiyosaki saying I should buy this.
0 · Reply
twitsblast
twitsblast Jul. 7 at 3:32 PM
$CNXU 🚨 $CHAI names new CFO, formerly with $RGNT, $GLMD, and $PLRZ. 💥
0 · Reply
stocks_2watch
stocks_2watch Jul. 7 at 1:46 PM
Look…the preclinical data on their Ten-Minute Tissue injectable looks promising for wound care but $CNXU is still pre-revenue with a fast burn rate. The latest 10Q showed a $2.3M net loss for the quarter and zero revenue. expanding their footprint at the new Vancouver adMare M4 hub is a great long-term move to scale the CXU platform, preclinical biotech burns cash fast. Still have trust but being carefull
0 · Reply
Mikiminingmouse
Mikiminingmouse Jul. 3 at 3:21 PM
$CNXU Big step forward them, with opening of their new Vancouver R&D lab at the adMare hub. great to see them hit these operational milestones as they steadily build momentum toward their 2027 FDA 510(k) submission
0 · Reply
topstockalerts
topstockalerts Jul. 2 at 12:35 PM
Pre Market Top Gainers PT2 $SURG $SDEV $TENX $UPXI $CNXU
0 · Reply
stocks_2watch
stocks_2watch Jun. 26 at 12:15 PM
$CNXU is scaling up the formulation tech with their CDMO for the 2027 510k submission, smooth transition from research to manufacturing so if they hits timelines this bio-tissue play is going to be massive
0 · Reply
mrrobot1337
mrrobot1337 Jun. 26 at 10:40 AM
Fresh Nasdaq debut with $CNXU and they already rang the bell this month. No royalty or licensing baggage on their IP. Highly scalable ECM platform targeting huge markets like wound care, one of those?
0 · Reply
kate8delgado8
kate8delgado8 Jun. 24 at 11:01 AM
$CNXU
0 · Reply
harrijakey
harrijakey Jun. 24 at 10:57 AM
$CNXU
0 · Reply
masonRhiiine
masonRhiiine Jun. 24 at 10:56 AM
$CNXU
0 · Reply
brennan_lucas999
brennan_lucas999 Jun. 24 at 10:55 AM
$CNXU
0 · Reply
calderinho
calderinho Jun. 24 at 10:53 AM
$CNXU
0 · Reply
Mikiminingmouse
Mikiminingmouse Jun. 23 at 3:02 PM
$CNXU good stuff
0 · Reply
mate8
mate8 Jun. 23 at 2:32 PM
$CNXU
0 · Reply
stocks_2watch
stocks_2watch Jun. 23 at 2:26 PM
$CNXU, has a Promising Webinar upcoming with their President & CEO Miles Harrison will discuss the high-growth markets Conexeu is targeting, including its recent expansion into regenerative aesthetics, sign Up: https://globalonemedia.zoom.us/webinar/register/WN_iPU1kk8VSHeyXl2xOwlKUA#/registration
0 · Reply
topstockalerts
topstockalerts Jun. 16 at 9:17 PM
$CNXU this one is sneaking up on people
0 · Reply
BuyOnRedSellOnGreen
BuyOnRedSellOnGreen Jun. 16 at 12:51 PM
$CNXU future zero
0 · Reply
mate8
mate8 Jun. 15 at 10:31 AM
$CNXU
0 · Reply
Mikiminingmouse
Mikiminingmouse Jun. 15 at 10:18 AM
$CNXU Nice to see some progress here. Manufacturing has been transferred to their CDMO partner and they're now producing material for final regulatory testing, which feels like another step toward commercialization.
0 · Reply
MadMaverick
MadMaverick Jun. 9 at 2:47 PM
$CNXU UPDATE Since our $11 entry, $CNXU has been volatile—hitting $18.79 before consolidating around $14.40. The thesis remains strong: Conexeu Sciences is hitting key manufacturing milestones for their CXU™ wound care platform ahead of that 2027 510(k) filing. We’re currently in a period of price discovery. Whether you’re long for the 2027 catalysts or playing the intraday moves, keep your risk tight and watch the volume as we stabilize above those sub-$12 levels. Communicated Disclaimer: stockresearchtoday.com/cnxu/ $CCTG $CHAI $AZI $PAVS
0 · Reply
brennan_lucas999
brennan_lucas999 Jun. 9 at 8:53 AM
$CNXU
0 · Reply
kate8delgado8
kate8delgado8 Jun. 9 at 8:39 AM
$CNXU
0 · Reply